Recent reports suggest oncologic equivalence between partial and radical nephrectomy for T1b and T2 renal cell carcinoma, with improved renal functional outcomes for partial nephrectomy. In this issue of Cancer , Ristau and colleagues provide further understanding of the limitations of nephron preservation in larger masses; and, ultimately, a randomized clinical trial may provide the most efficacious means of answering continued controversies and providing insight. See also pages 3839‐48 .
No takes yet. Share an insight, caveat, or question.
Derweesh et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: